Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
121.2 USD | -1.33% | +3.59% | -13.19% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.19% | 19.57B | |
+7.81% | 220B | |
+6.69% | 185B | |
+11.16% | 133B | |
+26.71% | 107B | |
-0.57% | 62.91B | |
+15.75% | 53.34B | |
-1.89% | 47.71B | |
-1.62% | 40.29B | |
+10.97% | 39.57B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Illumina Agrees to Pay BGI Genomics $325 Million in DNA-Sequencing Patent Case Settlement